1981
Established the first referral laboratory by founder and chairman Dr. Sushil Shah
Embracing Humble Beginnings. Achieving the Extraordinary.
1992
Commenced clinical research services
2001
- Ms. Ameera Shah starts building Metropolis and redefines our growth strategy
- Completed first major acquisition – Sudharma Kerala
- Introduced home service vertical
2006
Infused capital by ICICI Ventures
2010
Executed secondary transaction by Foxcreek Investment Limited (an affiliated company of Warburg Pincus)
2013
Expanded services of Metropolis to developing African countries
2015
Exit of Warburg Pincus; Promoters get management control; entry of Carlyle
2016
Inducted the new professional management team and rolled out Metropolis retail strategy
2019-20
- Strong thrust on retail expansion
- Initiated first Public-Private Partnership (PPP)
- Listed on the Indian stock exchanges successfully
2020-21
Designated as the first private diagnostic lab by the Government of India to start testing for Covid-19
2021-22
- Acquired Hitech Diagnostics Center to strengthen presence in South India
- Initiated network expansion project (90:30) to add 90 labs and 1,800 service collection centers in Tier 2 and Tier 3 cities
- 8 wholly-owned subsidiaries were absorbed into our Company
2022-23
- Launched Metropolis 3.0 strategy to broaden our consumer reach via Direct to Consumer (D2C) model with a focus on building chronic and wellness business
- Embarked on the journey of ESG (Environment, Social & Governance) – Identified our ESG focus areas using Materially Assessments Matrix based on GRI, SASB, and SDG frameworks
- Pioneered Diversity, Equity and Inclusion in the Indian Diagnostic Space with the launch of ‘Full Circle – Career 2.0’ offering flexible job opportunities for Women who wants to return to work after a career break
- Metropolis became the first ever organization in the Indian Diagnostics industry to launch the Employee Value Proposition (EVP) to strengthen its goal of becoming the ‘Employer Brand of Choice’
- 1st company in the Indian Diagnostics Chain space to achieve the ‘Great Place to Work’ Certification for our concerted efforts in building a commendable organization culture
1981
Established the first referral laboratory by founder and chairman Dr. Sushil Shah
1992
Commenced clinical research services
2001
- Ms. Ameera Shah starts building Metropolis and redefines our growth strategy
- Completed first major acquisition – Sudharma Kerala)
- Introduced home service vertical
2006
Infused capital by ICICI Ventures
2010
Executed secondary transaction by Foxcreek Investment Limited (an affiliated company of Warburg Pincus)
2013
Expanded services of Metropolis to developing African countries
2015
Exit of Warburg Pincus; Promoters get management control; entry of Carlyle
2016
Inducted the new professional management team and rolled out Metropolis retail strategy
2019-20
- Strong thrust on retail expansion
- Initiated first Public-Private Partnership (PPP)
- Listed on the Indian stock exchanges successfully
2020-21
Designated as the first private diagnostic lab by the Government of India to start testing for Covid-19
2021-22
- Acquired Hitech Diagnostics Center to strengthen presence in South India
- Initiated network expansion project (90:30) to add 90 labs and 1,800 service collection centers in Tier 2 and Tier 3 cities
- 8 wholly-owned subsidiaries were absorbed into our Company
2022-23
- Launched Metropolis 3.0 strategy to broaden our consumer reach via Direct to Consumer (D2C) model with a focus on building chronic and wellness business
- Embarked on the journey of ESG (Environment, Social & Governance) – Identified our ESG focus areas using Materially Assessments Matrix based on GRI, SASB, and SDG frameworks
- Pioneered Diversity, Equity and Inclusion in the Indian Diagnostic Space with the launch of ‘Full Circle – Career 2.0’ offering flexible job opportunities for Women who wants to return to work after a career break
- Metropolis became the first ever organization in the Indian Diagnostics industry to launch the Employee Value Proposition (EVP) to strengthen its goal of becoming the ‘Employer Brand of Choice’
- 1st company in the Indian Diagnostics Chain space to achieve the ‘Great Place to Work’ Certification for our concerted efforts in building a commendable organization culture
